Literature DB >> 3009142

Interaction of peptide YY with rat intestinal epithelial plasma membranes: binding of the radioiodinated peptide.

M Laburthe, B Chenut, C Rouyer-Fessard, K Tatemoto, A Couvineau, A Servin, B Amiranoff.   

Abstract

High affinity binding sites for peptide YY (PYY) have been identified and characterized in plasma membranes prepared from rat jejunal epithelium by studying the kinetics, stoichiometry, and chemical specificity of the interaction of 125I-labeled PYY with membranes. Binding of [125I]PYY was rapid, saturable, reversible, specific, and depended on temperature, pH, and ionic strength. In optimized steady state conditions of binding (2 h of incubation at 15 C), the degradation of both [125I] PYY and binding sites did not exceed 20%. The concentration dependence of PYY binding, determined by adding increasing concentrations of [125I]PYY, indicated that specific binding saturated at 2-3 nM peptide. Scatchard analysis revealed a single class of binding sites with a dissociation constant (Kd) of 434 +/- (SE) 56 pM and a binding capacity of 336 +/- 41 fmol/mg protein (n = 11). Identical results were obtained when increasing concentrations of unlabeled PYY were added to a fixed concentration of [125I]PYY, indicating that the radioiodinated peptide has the same apparent affinity as native PYY. Peptides structurally unrelated to PYY, such as members of the vasoactive intestinal peptide family, insulin, or cholecystokinin octapeptide, were unable to compete with [125I]PYY for binding to membranes. Rat, human, and avian pancreatic polypeptides, which display, respectively, 42%, 47%, and 53% homology with PYY, did inhibit [125I]PYY binding but with an approximate or equal to 100,000-fold lower potency than PYY, indicating the strict structural requirement for recognition by PYY binding sites. In contrast, natural or synthetic neuropeptide Y, which has 25 out of 36 amino acids in common with PYY, retained a high affinity for PYY binding sites [only 4.7 +/- 1.2 (n = 5) times lower than that of PYY]. Specific [125I]PYY binding was particularly high in the upper small intestine and could not be detected in stomach, large intestine, or liver. These findings indicate that rat small intestinal epithelium expresses specific binding sites for the candidate gut hormone PYY that also binds the neuropeptide Y with high affinity, suggesting that the two peptides may regulate the function of small intestinal epithelium, through interaction with a common receptor site.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009142     DOI: 10.1210/endo-118-5-1910

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

1.  BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist.

Authors:  Y Dumont; A Cadieux; H Doods; L H Pheng; R Abounader; E Hamel; D Jacques; D Regoli; R Quirion
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

2.  Constitutive neuropeptide Y Y(4) receptor expression in human colonic adenocarcinoma cell lines.

Authors:  H M Cox; I R Tough; D W Zandvliet; N D Holliday
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 3.  New insights into the fatty acid-binding protein (FABP) family in the small intestine.

Authors:  Philippe Besnard; Isabelle Niot; Hélène Poirier; Lionel Clément; André Bernard
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

4.  Neuropeptide Y antagonises secretagogue evoked chloride transport in rat jejunal epithelium.

Authors:  H M Cox; A W Cuthbert
Journal:  Pflugers Arch       Date:  1988-11       Impact factor: 3.657

5.  Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.

Authors:  H Gicquiaux; M Tschöpl; H N Doods; B Bucher
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

6.  Characterization of two novel proabsorptive peptide YY analogs, BIM-43073D and BIM-43004C.

Authors:  D A Litvak; H Iseki; B M Evers; G H Greeley; M R Hellmich; K Iwase; A Balasubramaniam; C M Townsend
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

7.  Characterization and distribution of alpha 2-adrenergic receptors in the human intestinal mucosa.

Authors:  P Valet; J M Senard; J C Devedjian; V Planat; R Salomon; T Voisin; G Drean; A Couvineau; D Daviaud; C Denis
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Peptide YY release after intraduodenal, intraileal, and intracolonic administration of nutrients in rats.

Authors:  X Fu-Cheng; Y Anini; J Chariot; T Voisin; J P Galmiche; C Rozé
Journal:  Pflugers Arch       Date:  1995-11       Impact factor: 3.657

9.  Peptide YY enhances NaCl and water absorption in the rat colon in vivo.

Authors:  M Okuno; T Nakanishi; Y Shinomura; T Kiyohara; H Ishikawa; S Tarui
Journal:  Experientia       Date:  1992-01-15

Review 10.  Peptides and epithelial growth regulation.

Authors:  R A Goodlad; N A Wright
Journal:  Experientia       Date:  1987-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.